Join to View Full Profile
12605 E 16th AveAurora, CO 80045
Phone+1 720-848-0000
Dr. Rabinovitch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 1990 - 1993
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalInternship, Internal Medicine, 1989 - 1990
Albert Einstein College of MedicineClass of 1989
Certifications & Licensure
CO State Medical License 1994 - 2025
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery Start of enrollment: 2013 Aug 01
- RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE Start of enrollment: 2014 Jun 30
Publications & Presentations
PubMed
- Outcomes of Haplo-Cord Versus Dual Cord Transplants: A Single-Center Retrospective Analysis.Andrew Kent, Kellen B Gil, Michael K Jones, Brooke Linden, Enkhee Purev
Transplantation and Cellular Therapy. 2025-04-01 - TIP25-242: The PREDICT II Registry: A Prospective Study to Evaluate the Clinical Utility of a 7-Gene Predictive Biosignature on Treatment Decisions in Patients With Du...Rachel Rabinovitch, Pat Whitworth, Pat Borgen, Anna Daily, Steve Shivers
Journal of the National Comprehensive Cancer Network. 2025-03-28 - CLO25-061: 7-Gene Biosignature Reclassified Women With DCIS Meeting NCCN Guideline (RTOG 9804-Like) Low-Risk Criteria as Molecular High Risk.Chirag Shah, Frank A Vicini, Eileen P Connolly, Rachel A Rabinovitch, Brian Czerniecki
Journal of the National Comprehensive Cancer Network. 2025-03-28
Press Mentions
Ashkenazi Jewish Women Who Know They Have BRCA Mutation Have Better Breast Cancer OutcomesAugust 13th, 2019
Knowing BRCA Status Associated with Better Breast Cancer Outcomes Even Without SurgeryJuly 8th, 2019
Largest Ever Study of Male Breast Cancer Treatment Shows More Mastectomy, Less Radiation Than in Female DiseaseFebruary 10th, 2016
Professional Memberships
- Member
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
